William Sandlund

Michael Burry's series on the HK market is a good read. "The largest Hong Kong companies are widely known and poorly understood. These stocks have had 1929-style crashes while the businesses kept growing." Check it out: substack.com/home/post/p-19…

Read the story here: as.ft.com/r/238b0d2f-eca…

Few people recognise how embedded Chinese businesses are in AI supply chains. But investors do! And they are betting Chinese battery and energy storage system companies will be the main game in town for the frenzied global AI buildout.

As rupee falls below the 90/$ threshold today, some facts about the booming equity markets: India has underperformed compared to its peers with the widest gap in 30 years. @wtbs_ @christopherkay @haohsiang0509 @FT as.ft.com/r/d3373c1f-ed8…

What's driving the world's best-performing stock market? Read my story (for free) to find out...

External renminbi loans, deposits and bond investments by Chinese banks quadrupled to more than Rmb3.4tn ($480bn) over the past five years, as Beijing steps up efforts to expand the currency’s role in global finance and reduce exposure to the US dollar on.ft.com/3L31hGN

Read the full story here: on.ft.com/46dgsWx

The rise of DeepSeek has rekindled interest in China's innovative small businesses — known as 小巨人, or "little giants" — developing technology that can drive future economic growth. Beijing's little-known stock exchange is becoming an IPO hub for these small tech companies. The businesses listed there make everything from data centre cooling equipment and battery materials to the carbon fibre used in aircraft and satellites.

Read the full story here: on.ft.com/4eMcN45

Biotech companies from mainland China are pushing boundaries in fundamental cancer research and investors are taking notice. The Hang Seng Biotech index is up over 60% this year, with companies like 3SBio Inc. and Akeso Biopharma leading gains as they sign licensing agreements with western pharmaceutical groups for new drugs that have the potential to transform how we treat cancer.

Read the full story here: on.ft.com/44tiEb1

Taiwan's central bank has warned foreign investors against violating its capital controls. The warning comes as it seeks to rein in the New Taiwan dollar’s sharp rally without being labelled a currency manipulator by the US.

Read the full story here: on.ft.com/40zmehq

“In China every yield is going down except for the dividend yield.” China's big banks have become bond proxies as investors hunt for yield at a time of record-low interest rates. The country's insurance industry is helping drive the trend.

2/ Retail investors still drive mainland Chinese equities and they have yet to get behind their home market. Read the full story here: on.ft.com/44HmDkg

1/ Trade tensions, deflation, falling property prices. By now all familiar challenges for China's economy. Less talked about is the lacklustre performance of A-shares so far this year, which stands in stark contrast to a bull market in Hong Kong.

Bets that currency deals will form part of trade negotiations with the US have helped lift a string of Asian currencies against the dollar, as traders look for signs that countries will offer to scale back intervention to appease President Donald Trump. on.ft.com/4kAt125

Chinese investors are pouring money into Hong Kong at historic levels, driving the city's stock market to outperform mainland equities by the widest margin since 2008. A weak onshore economy and lack of listed AI companies in China are driving the trend. on.ft.com/4kpbFVC

Donald Trump's erratic tariff threats have driven up volatility in G7 and EM currencies to levels last seen during the collapse of Silicon Valley Bank and Credit Suisse in March 2023. This heightened uncertainty has spurred greater demand for FX hedging among corporates and investors seeking to mitigate risks in a rapidly changing world. Read the full story here: on.ft.com/4cAmcuF